Gene · 8817
Papers1,397
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,397
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fibroblast growth factor 18 attenuates renal fibrosis via AMPK/NOX4 pathway in mice. | Biochem Biophys Res Commun | 2025 | 40311293 | PubTator, text mining | PubMed |
| Correction to"Injectable Microgels with Hybrid Exosomes of Chondrocyte-Targeted FGF18 Gene-Editing and Self-Renewable Lubrication for Osteoarthritis Therapy". | Adv Mater | 2025 | 40285569 | PubTator, text mining | PubMed |
| Efficacy of intra-articular injections for the treatment of osteoarthritis: A narrative review. | Osteoarthr Cartil Open | 2025 | 40144957 | PubTator, text mining | PubMed |
| Enhanced insights into the genetic architecture of 3D cranial vault shape using pleiotropy-informed GWAS. | Commun Biol | 2025 | 40087503 | PubTator, text mining | PubMed |
| Patterning effects of FGF17 and cAMP on generation of dopaminergic progenitors for cell replacement therapy in Parkinson's disease. | Stem Cells | 2025 | 40071608 | PubTator, text mining | PubMed |
| Assessing serum and biopsy biomarkers for predicting allergic asthma severity: a comprehensive study. | J Asthma | 2025 | 39932249 | PubTator, text mining | PubMed |
| Molecular Dynamics of Breast Cancer Subtypes: The Role of FAM83H-AS1 Long Non-coding RNA in Breast Cancer Metastasis. | Breast Cancer Res Treat | 2025 | 39891867 | PubTator, text mining | PubMed |
| High FGF18 expression levels predict poor prognosis in endometrial carcinoma patients and promote tumor growth and metastasis. | J Int Med Res | 2025 | 39852234 | PubTator, text mining | PubMed |
| 3D bio-printed proteinaceous bioactive scaffold loaded with dual growth factor enhanced chondrogenesis and in situ cartilage regeneration. | Bioact Mater | 2025 | 39845130 | PubTator, text mining | PubMed |
| Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence. | J Nanobiotechnology | 2025 | 39844298 | PubTator, text mining | PubMed |
| Enhanced yield and subtype identity of hPSC-derived midbrain dopamine neuron by modulation of WNT and FGF18 signaling. | bioRxiv | 2025 | 39829874 | PubTator, text mining | PubMed |
| Senolytic therapy combining Dasatinib and Quercetin restores the chondrogenic phenotype of human osteoarthritic chondrocytes by the release of pro-anabolic mediators. | Aging Cell | 2025 | 39402753 | PubTator, text mining | PubMed |
| Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth. | Nat Struct Mol Biol | 2025 | 39304765 | PubTator, text mining | PubMed |
| Refining of cancer-specific genes in microsatellite-unstable colon and endometrial cancers using modified partial least square discriminant analysis. | Medicine (Baltimore) | 2024 | 39969322 | PubTator, text mining | PubMed |
| Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance. | Biomolecules | 2024 | 39766329 | PubTator, text mining | PubMed |
| Research Progress of Ribosomal Proteins in Reproductive Development. | Int J Mol Sci | 2024 | 39684863 | PubTator, text mining | PubMed |
| Comprehensive in silico analysis of prognostic and immune infiltrates for FGFs in human ovarian cancer. | J Ovarian Res | 2024 | 39385288 | PubTator, text mining | PubMed |
| HIF-1α induced FGF18 alleviates renal ischemia/reperfusion injury via YAP. | FASEB J | 2024 | 39373977 | PubTator, text mining | PubMed |
| Targeted Therapy of Osteoarthritis via Intra-Articular Delivery of Lipid-Nanoparticle-Encapsulated Recombinant Human FGF18 mRNA. | Adv Healthc Mater | 2024 | 39363784 | PubTator, text mining | PubMed |
| Exosome-loaded biomaterials for tendon/ligament repair. | Biomater Transl | 2024 | 39351162 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8817/papers?page=3